Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37
about
Roles of d-Amino Acids on the Bioactivity of Host Defense PeptidesAntimicrobial Peptides as Potential Alternatives to Antibiotics in Food Animal IndustryPotential Use of Antimicrobial Peptides as Vaginal Spermicides/MicrobicidesComplementary and Alternative Medicine Treatment Options for Otitis Media: A Systematic ReviewPerspective of Use of Antiviral Peptides against Influenza VirusAntiviral potential of cathelicidinsNew therapeutic approaches for treatment of tularaemia: a reviewHigh-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.The Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory TherapyCationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections.Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses.Collectins, H-ficolin and LL-37 reduce influence viral replication in human monocytes and modulate virus-induced cytokine production.Citrullination alters immunomodulatory function of LL-37 essential for prevention of endotoxin-induced sepsis.Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo.Perspectives for clinical use of engineered human host defense antimicrobial peptidesCathelicidin LL-37 and HSV-1 Corneal Infection: Peptide Versus Gene Therapy.LL-37 modulates human neutrophil responses to influenza A virus.Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.New treatments for influenzaRandomized controlled trial of calcitriol in severe sepsis.The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus.A cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohortCathelicidin antimicrobial protein, vitamin D, and risk of death in critically ill patients.D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infectionsVitamin D insufficiency is common in Ugandan children and is associated with severe malaria.Identifying the Critical Domain of LL-37 Involved in Mediating Neutrophil Activation in the Presence of Influenza Virus: Functional and Structural AnalysisModulation of the immune response to respiratory viruses by vitamin D.Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells.The Human Antimicrobial Protein Bactericidal/Permeability-Increasing Protein (BPI) Inhibits the Infectivity of Influenza A VirusThe human side of influenza.Vitamin D3 Supplementation and Antibiotic Consumption - Results from a Prospective, Observational Study at an Immune-Deficiency Unit in Sweden.Vitamin D's potential to reduce the risk of hospital-acquired infections.The Role of Cathelicidin LL-37 in Cancer Development.Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans.The role of vitamin D in prevention and treatment of infection.Cationic host defence peptides: potential as antiviral therapeuticsLittle peptide, big effects: the role of LL-37 in inflammation and autoimmune diseaseMembrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design.Impact of vitamin D on immune function: lessons learned from genome-wide analysis.Induction of the human cathelicidin LL-37 as a novel treatment against bacterial infections.
P2860
Q26744734-E40A3D25-39A7-442D-8D80-7C5F6474A03DQ26751499-E78FA87E-121A-448D-B91F-4D94FA6AC65AQ26765450-2F4CA574-3586-4BCC-8644-AF103F884CA5Q26766291-1E1F2D07-4D99-4D30-8357-6E2AF7708CFEQ26780434-270AFB44-24AC-42C2-BD8C-054C98A0B71AQ27006576-16B59C74-0760-4965-A7ED-54642A6D9DB3Q27027375-BCA36E45-1A73-467B-BB81-582D1C7FEB1DQ27692605-DE326FA7-2183-4CFD-9152-098EDABD155FQ28077916-695BC168-CBFF-45BF-8996-D27F9B26C4FFQ30151971-0BB80F06-52F2-45CF-BF4F-DA443F84EA89Q30374098-09228190-FF15-47A9-BACA-0273A14AD047Q30395313-B4DE3A45-B25A-49D7-ACE6-03318C02D41BQ33675249-12B218B1-E2EC-4EC9-8604-01EC65C22F1EQ33700171-2EFEE35A-9C0C-45BC-91A8-49574D555766Q33700825-25B5D8EF-9802-4693-87B4-420B5FCFE34EQ33704754-40379977-8ECB-41BD-87EC-18787CD24A1DQ34341371-118BB3FC-A531-40AC-8C66-88E034CCA2B7Q34356485-A8018A54-FE4E-479C-80E7-4A4EE09618ABQ34413797-B234E009-D304-45EC-BAB4-15C0E60D4A0FQ34425809-7E6A540C-BEA9-4BF8-9E7E-334FB17907C5Q34983753-9DA8F915-B827-4744-8B8F-972AA168214BQ35151476-A31B901F-87E2-46F4-B379-3637DA394DD1Q35170224-23C7140A-555A-435D-B719-7A7612A91292Q35185982-8A74BA7F-D887-4FDF-AA86-D36A8482DA9BQ35485397-D3F32E9A-F730-4631-B5CC-7DCEF8E17953Q35755845-9553C705-26AA-4AEB-AECE-C8014841210BQ35808859-B506E4E3-A00C-4DCF-B763-F6A2C3FD517FQ35886054-5F592F78-F323-498A-9639-A0D1404929C2Q36044173-EDC1C15A-BF8B-4A7F-A7A8-167437A02CD0Q36055988-E03A579E-A886-4534-AE9B-574D9D11C626Q36140859-39CA3603-FBD4-41A2-AE47-BD3F2661D80FQ36187615-C0D96F93-E629-47C4-9F41-A0F88FD568F2Q36465085-A705D409-FEF9-4EB0-B3D9-66F19A2D510AQ36650606-5CE425FA-AF65-4380-80FF-6BFDF46C3BC5Q37131135-8AC11189-A65F-413E-9C80-82B9170EE50CQ37177085-2CDD1BCC-7706-4FA4-A878-2B3FFFA23848Q37332300-004F79A5-7870-4610-8A2D-57526F93ABC7Q37639825-03E4B98D-F3CD-4505-B449-25D8823B12ACQ37725587-4FFA1E0C-417E-4C90-B568-8FD460E26B09Q38018928-B1BBC262-1111-45DC-8CE4-99B7F9D4D3B8
P2860
Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antiviral activity and increas ...... y the human cathelicidin LL-37
@ast
Antiviral activity and increas ...... y the human cathelicidin LL-37
@en
Antiviral activity and increas ...... y the human cathelicidin LL-37
@nl
type
label
Antiviral activity and increas ...... y the human cathelicidin LL-37
@ast
Antiviral activity and increas ...... y the human cathelicidin LL-37
@en
Antiviral activity and increas ...... y the human cathelicidin LL-37
@nl
prefLabel
Antiviral activity and increas ...... y the human cathelicidin LL-37
@ast
Antiviral activity and increas ...... y the human cathelicidin LL-37
@en
Antiviral activity and increas ...... y the human cathelicidin LL-37
@nl
P2093
P2860
P50
P3181
P1433
P1476
Antiviral activity and increas ...... y the human cathelicidin LL-37
@en
P2093
Annie Mackellar
Anthony A Nash
Pavel Svoboda
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0025333
P407
P577
2011-10-21T00:00:00Z